More people survive cancer now than ever before. I see my role as being a strong advocate for my patients, fully informing them of their options and supporting them throughout their treatment programs. Dr. Fer is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.

Misho Hubka, MD, is a board-certified thoracic surgeon. His special medical interests include Robotic and Video-Assisted Thoracoscopic Surgery (VATS), lung cancer surgery, esophageal cancer surgery, and complex surgery for benign and malignant disease of the lung, chest wall, esophagus and mediastinum.Dr. Hubka is a member of the Society of Thoracic Surgeons, STS Patient Safety Workforce and Western Thoracic Surgical Association. He was named a Top Doctor by Seattle Met Magazine in 2017, 2018 and 2019. Dr. Hubka is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Hiatal Hernia, Hernia, Neuroendocrine Tumor, Gastrostomy, and Endoscopy.

Francis Senecal is an Oncologist in Tacoma, Washington. Dr. Senecal is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Bone Marrow Aspiration. Dr. Senecal is currently accepting new patients.

Sachin Kumbhar, MD, specializes in gastrointestinal, genitourinary, thoracic and cardiac imaging, and nuclear medicine. Dr. Kumbhar is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Lung Nodules, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Fibrolamellar Carcinoma, and Gastrostomy.

Carolyn Wang is a Radiologist in Seattle, Washington. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, and Penectomy.

Robert Randolph is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Randolph is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Hemangioma Thrombocytopenia Syndrome, and Pleuropulmonary Blastoma.

"Dr. Evan Ong most recently received the 2023 Cancer Surgery Top Doc designation and has received the Seattle Top Doc award for multiple consecutive years. Dr. Ong's clinical practice focuses on the treatment of all gastrointestinal cancers with particular interest in treatment options for pancreatico-biliary cancers as well as regional and metastatic disease. He offers state-of-the-art treatment including minimally invasive and robotic surgery for hepatic and pancreatic tumors, microwave and bipolar radiofrequency ablation, irreversible electroporation (Nano-knife) as well as Hyperthermic Intraperitoneal Chemoperfusion (HIPEC), a treatment option for cancers that have disseminated to the peritoneal cavity. Dr. Ong's philosophy of care is ""Qui Audet...Cura"" - ""Who Dares...Cures.""". Dr. Ong is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Familial Colorectal Cancer, Pseudomyxoma Peritonei, Hepato-Pancreato-Biliary Surgery, and Pancreaticoduodenectomy.

Elena Chiorean is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Chiorean is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Chiorean is currently accepting new patients.

Shailender Bhatia is a Hematologist and an Oncologist in Seattle, Washington. Dr. Bhatia is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Merkel Cell Carcinoma, Melanoma, Neuroendocrine Tumor, and Melanoma of the Eye.

"Dr. Paulson is passionate about practicing medical oncology, as it seamlessly integrates cutting-edge scientific advancements with the compassionate essence of medicine. Her clinical interests focus on skin cancer and solid tumor immunotherapy while Dr. Paulson’s appreciation lies in the ability to establish meaningful connections with patients and their families, throughout their care. Dr. Paulson firmly believes that optimal cancer care is achieved through a collaborative, team-based approach and takes great joy in working alongside an interdisciplinary team of dedicated healthcare professionals. Recognizing the pivotal role of patients in their own care, she is committed to transparent communication, ensuring that everyone understands the ""how and why"" behind their personalized treatment plans. In addition to her clinical role, Dr. Paulson is a skilled clinical researcher, serving as the Principal Investigator for various clinical trials aimed at bringing the latest advancements in cancer care and the lead for the Center for Immuno-Oncology at the Paul G Allen Research Center. Furthermore, she is dedicated to nurturing the next generation of medical professionals, actively supporting medical students at the Washington State University Elson E. Floyd Medical School in Everett, particularly in advancing their understanding of emerging immunotherapies. In 2023, Dr. Kelly Paulson was honored as the inaugural recipient of the Jeff Ward Award, established to memorialize him. This distinguished award acknowledges medical staff members who contribute positively to the Edmonds community through exceptional leadership, mentorship, or improvements in patient care. Also, she is a 2024 Castle Connolly Top Doctor. Dr. Paulson sees patients at the Edmonds and First Hill Swedish Cancer Institute locations.". Dr. Paulson is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Merkel Cell Carcinoma, Neuroendocrine Tumor, Small Cell Lung Cancer (SCLC), and Colorectal Cancer.

Ludmila Martin is an Oncologist in Puyallup, Washington. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Neuroendocrine Tumor. Dr. Martin is currently accepting new patients.

John Paul Flores, MD, is a board-certified medical oncologist. He cares for patients with blood disorders and all forms of cancer.Dr. Flores takes the time to guide his patients on their wellness journey, listening to what they say, answering their questions and providing a path forward with hope. In this complex, fast-growing field where new treatments are approved for clinical use regularly, Dr. Flores relies on the expertise of a team of surgeons, pathologists, radiation oncologists and other colleagues to stay at the forefront of cancer treatment and to provide comprehensive, patient-centered care. Dr. Flores is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, WT1-Related Wilms Tumor Syndromes, Prostatectomy, and Splenectomy.

Dr. Gold is a multiple time recipient of the Seattle Top Doctor Award and most recently received the 2024 Seattle Magazine Top Doc Award. Dr. Gold is Director of Clinical Research and the Program Leader for the Gastrointestinal (GI) Oncology Program at the Swedish Cancer Institute in Seattle, Washington. In 1991, Dr. Gold obtained his degree in medicine with a distinction in research at the University of Miami School of Medicine in Florida. He then completed an internal medicine internship and residency at the University of Washington. Dr. Gold received the Amgen Oncology Fellowship Award while he was training in medical oncology at the University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center. Presently, he is board certified in medical oncology. Dr. Gold’s clinical investigations on GI tumors, and particularly colorectal cancer treatment, can be found in peer-reviewed publications like the Journal of Clinical Oncology, Seminars in Oncology, and Cancer Investigation. Furthermore, he currently serves as a member of the NCI Colon Task Force, and the Southwest Oncology Group, where he serves as the subcommittee co-chair for colon cancer. In his free time, Dr. Gold enjoys photography and spending time with his wife and three sons. Dr. Gold is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Neuroendocrine Tumor, and Lynch Syndrome.

Dr. Byrd is board-certified in internal medicine, oncology and hematology. He completed a fellowship in hematology/oncology at Oregon Health & Science University, where he also completed his residency and internship in internal medicine. He received his medical degree from the University of Texas Southwestern Medical School in Dallas. Dr. Byrd is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Familial Colorectal Cancer, Neuroendocrine Tumor, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

Clancy J. Clark, MD is a board-certified surgeon specializing in hepatobiliary and pancreas surgery with expertise in minimally invasive and robotic surgical techniques. His practice focuses on the surgical management of liver, bile duct, and pancreatic cancers, as well as benign conditions such as bile duct injuries, pancreatitis, and liver tumors. With fellowship training from the Mayo Clinic and extensive experience in complex surgical oncology, Dr. Clark is committed to providing the highest standard of care using the latest advancements in surgical technology.Dr. Clark strives to build trust, transparency, and shared decision-making with his patients. He will take the time to ensure patients and their families fully understand their diagnosis and treatment options, empowering them to make informed decisions. Surgery can be overwhelming, and Dr. Clark helps guide patients through the process with clarity and compassion. By utilizing minimally invasive techniques, Dr. Clark aims to improve surgical outcomes, reduce recovery times, and enhance overall quality of life.Dr. Clark is an internationally recognized surgeon and researcher focused on improving outcomes in hepatobiliary and pancreatic surgery, with an emphasis on surgical innovation, healthcare informatics, and clinical trials for gastrointestinal cancers. He has led national studies evaluating surgical risk assessment, perioperative optimization, and novel treatment strategies. Additionally, Dr. Clark is actively involved in shaping surgical education and policy through leadership roles in national surgical societies.Outside of work, Dr. Clark enjoys fly fishing, skiing, and traveling.  He has a passion for Formula One racing, which reflects his appreciation for precision, innovation, and continuous improvement—principles that also guide his surgical practice. Dr. Clark is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Acute Pancreatitis, Pancreatectomy, and Small Bowel Resection.

Jacob Mathew, MD is a fellowship trained, board-certified hematologist/oncologist who believes we are born with essential dignity and his goal is to preserve that dignity, at times using his medical knowledge and at other times just being there for his fellow man. Dr. Mathew believes that the practice of medicine should be evidence-based while simultaneously incorporating the art of medicine. To him, the art of medicine means he needs to be the advocate for his patients. He also hopes to empower his patients to play a pivotal role in their medical care and decision making by teaching them at least the basics of their disease. Dr. Mathew is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Osteotomy, and Bone Marrow Aspiration.

Vincent Picozzi, Jr., MD, specializes in pancreatic cancer, gastrointestinal cancer (pancreaticobiliary), genitourinary cancer, hematologic oncology (lymphomas) and myelodysplasia. Dr. Picozzi is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Andrea Veatch is an Oncologist in Puyallup, Washington. Dr. Veatch is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Dehydration, and Testicular Yolk Sac Tumor. Dr. Veatch is currently accepting new patients.

Shayan Irani, MD, specializes in pancreaticobiliary diseases, gastrointestinal oncology, Barrett's Esophagus, gastrointestinal stenting, endoscopic mucosal resection, submucosal dissection, radio frequency ablation and other advanced therapeutic and emerging techniques.Dr. Irani enjoys spending time with his wife and daughter, the outdoors, traveling and Scuba diving. Dr. Irani is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Cholecystitis, Gastrointestinal Fistula, Gallbladder Disease, Endoscopy, and Gastric Bypass.

Michael Harris is a Hematologist Oncology specialist and a Hematologist in Puyallup, Washington. Dr. Harris is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Paget Disease of the Breast, Familial Prostate Cancer, Ampullary Cancer, and Poststreptococcal Glomerulonephritis.